Rodger Novak

Meet Rodger Novak

Rodger is one of the three co-founders of CRISPR Therapeutics, which aims to treat diseases using CRISPR/Cas9 gene editing technology. The company recently announced that the first patients had been treated with CTX001, a CRISPR/Cas9 therapy β-thalassemia and sickle cell disease.